Search clinical trials for: Kallikrein

Total 20 results

Techpool Bio-Pharma Co., Ltd.

Unknown

The Study to Reevaluate the Safety and Efficacy of Human Urinary Kallikrein

Cerebral Infarction

China
DiaMedica Therapeutics Inc

Completed

A Study to Evaluate the Safety and Effectiveness of DM199 in Healthy Subjects and Type 2 Diabetes Patients

Diabetes Type 2

Netherlands
Changzhou Qianhong Bio-pharma Co., Ltd.

Completed

Study to Assess PK, Safety and Tolerability in Healthy Subjects

Acute Ischemic Stroke

China
The Second Hospital of Hebei Medical University

Completed

Human Urinary Kallidinogenase Improve Short Term Motor Functional Outcome of Acute Ischemia Stroke Patients

Stroke, Acute

China
DiaMedica Therapeutics Inc

Recruiting

Treatment of Acute Ischemic Stroke (ReMEDy2 Trial) (ReMEDy2)

Stroke | Ischemic Stroke | Acute Stroke

United States
Second Affiliated Hospital, School of Medicine,...

Withdrawn

Study of Urinary Kallikrein to Enhance Collateral Circulation in Symptomatic Intracranial Atherosclerosis

Intracranial Arteriosclerosis | Collateral Circulation | Anterior Cerebral Circulation Infarction

China
DiaMedica Therapeutics Inc
Novotech (Australia) Pty Limited

Completed

An Open Label, Phase 1b, Ascending Dose Study of DM199

Stroke

Australia
DiaMedica Therapeutics Inc

Completed

Evaluation to Assess Safety and Tolerability of DM199 in Subjects With Acute Ischemic Stroke (ReMEDy1)

Acute Ischemic Stroke

Australia
Jinling Hospital, China

Unknown

Tissue Kallikrein Preventing the Restenosis After Stenting of Symptomatic MCA Atherosclerotic Stenosis

Cerebrovascular Disease

China
OPKO Health, Inc.

Completed

4Kscore Using Serum Stored Uncentrifuged

Prostate Cancer

United States
Bernstein, Jonathan A., M.D.
Dyax Corp.

Unknown

Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema (ACE)

Angioedema

United States
Beijing Tsinghua Chang Gung Hospital
Peking University People's Hospital

Not yet recruiting

Effects of Human Urinary Kallidinogenase on Early Improvement and Functional Outcomes in Acute Ischemic Stroke (TK-SPEED)

Acute Ischemic Stroke | Functional Outcomes
Huisheng Chen

Unknown

The Metabolism Research of KLK Treating Acute Cerebral Ischemic Stroke: Focus on Drug Frequency-Efficacy Relationship (MAISKFE)

Cerebral Infarction

China
Huashan Hospital
Shanghai Stroke Association

Not yet recruiting

Efficacy and Safety of Human Urinary Kallidinogenase Combined With Endovascular Therapy in Acute Ischemic Stroke With Large Vessel Occlusion (HEAL)

Acute Ischemic Stroke
Hospital de Clinicas de Porto Alegre

Unknown

Therapeutic Efficacy of Oral L-Ornithine-L-Aspartate on Minimal Encephalopathy (PORTOALEGRE)

Hepatic Encephalopathy

Brazil
The Second Hospital of Hebei Medical University

Completed

Effects of Urinary Kallidinogenase in Acute Ischemic Stroke Patients With Abnormal Glucose Metabolism

Acute Ischemic Stroke | Abnormal Glucose Metabolism
First Affiliated Hospital, Sun Yat-Sen University

Not yet recruiting

Efficacy and Safety of Urinary Kallidinogenase in the Treatment of Acute Ischemic Stroke Combined With Type 2 Diabetes Mellitus (TK-SEEK)

Type 2 Diabetes | Acute Ischemic Stroke

China
XuanwuH 2

Completed

Multi-modality MRI Study on Effect to Collateral Circulation and Blood Perfusion of Acute Cerebral Infarction by Human Urinary Kallidinogenase

Cerebral Infarction

China
Yi Yang

Not yet recruiting

Safety and Efficacy of Urinary Kallidinogenase for Large Artery Atherosclerosis Acute Ischemic Stroke

Acute Ischemic Stroke

China
Xuanwu Hospital, Beijing

Completed

Evaluation Of HUK in Acute Stroke Patients: MRS and CTP

Acute Ischemic Stroke

3

Subscribe